Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuroblastoma Origin and Therapeutic Targets for Immunotherapy
И. В. Холоденко, Daniel Kalinovsky, Igor I. Doronin, et al.
Journal of Immunology Research (2018) Vol. 2018, pp. 1-25
Open Access | Times Cited: 153

Showing 1-25 of 153 citing articles:

Molecular targeting therapies for neuroblastoma: Progress and challenges
Atif Zafar, Wei Wang, Gang Liu, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 2, pp. 961-1021
Open Access | Times Cited: 254
Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy
Bassel Nazha, Cengiz Inal, Taofeek K. Owonikoko
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 219
Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma
Lihong Wang-Bishop, Mohamed Wehbe, Daniel Shae, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 1, pp. e000282-e000282
Open Access | Times Cited: 137
Therapy resistance in neuroblastoma: Mechanisms and reversal strategies
Xia Zhou, Xiaokang Wang, Nan Li, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 23
Emerging Trends in Neuroblastoma Diagnosis, Therapeutics, and Research
Rishabh Sharma, Jaya Yadav, Sajad Ahmad Bhat, et al.
Molecular Neurobiology (2025)
Closed Access | Times Cited: 1
Individual risk and prognostic value prediction by interpretable machine learning for distant metastasis in neuroblastoma: A population-based study and an external validation
Shan Li, Jinkui Wang, Zhaoxia Zhang, et al.
International Journal of Medical Informatics (2025) Vol. 196, pp. 105813-105813
Closed Access | Times Cited: 1
Current management of neuroblastoma and future direction
Elizabeth R Pastor, Shaker A. Mousa
Critical Reviews in Oncology/Hematology (2019) Vol. 138, pp. 38-43
Closed Access | Times Cited: 68
Hypoxia Predicts Poor Prognosis in Neuroblastoma Patients and Associates with Biological Mechanisms Involved in Telomerase Activation and Tumor Microenvironment Reprogramming
Davide Cangelosi, Martina Morini, Nicolò Zanardi, et al.
Cancers (2020) Vol. 12, Iss. 9, pp. 2343-2343
Open Access | Times Cited: 53
Role and toxicity of radiation therapy in neuroblastoma patients: A literature review
Qin Zhao, Yang Liu, Yuyu Zhang, et al.
Critical Reviews in Oncology/Hematology (2020) Vol. 149, pp. 102924-102924
Closed Access | Times Cited: 45
Minibody-Based and scFv-Based Antibody Fragment-Drug Conjugates Selectively Eliminate GD2-Positive Tumor Cells
Daniel Kalinovsky, И. В. Холоденко, А. В. Кибардин, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1239-1239
Open Access | Times Cited: 15
Overcoming Biological Barriers in Neuroblastoma Therapy: The Vascular Targeting Approach with Liposomal Drug Nanocarriers
Fabio Pastorino, Chiara Brignole, Daniela Di Paolo, et al.
Small (2019) Vol. 15, Iss. 10
Closed Access | Times Cited: 38
B4GALNT1 induces angiogenesis, anchorage independence growth and motility, and promotes tumorigenesis in melanoma by induction of ganglioside GM2/GD2
Hideki Yoshida, Lisa Koodie, Kari Jacobsen, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 36
RNA Sequencing-Based Identification of Ganglioside GD2-Positive Cancer Phenotype
Maxim Sorokin, И. В. Холоденко, Daniel Kalinovsky, et al.
Biomedicines (2020) Vol. 8, Iss. 6, pp. 142-142
Open Access | Times Cited: 34
Therapeutic efficacy of antibody-drug conjugates targeting GD2-positive tumors
Daniel Kalinovsky, А. В. Кибардин, И. В. Холоденко, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 6, pp. e004646-e004646
Open Access | Times Cited: 19
17q Gain in Neuroblastoma: A Review of Clinical and Biological Implications
Vid Mlakar, Isabelle Dupanloup, Fanny Gonzales, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 338-338
Open Access | Times Cited: 4
Revolutionizing pediatric neuroblastoma treatment: unraveling new molecular targets for precision interventions
Min Zheng, Ankush Kumar, Vishakha Sharma, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 4
Influence of stromal neural crest progenitor cells on neuroblastoma radioresistance
Carlos Huertas-Castaño, Laura Martínez-López, P. Cabrera, et al.
International Journal of Radiation Biology (2025), pp. 1-11
Closed Access
Synthesis and Biological Evaluation of a New Biphenyl-Based Organogold(III) Complex with In Vitro and In Vivo Anticancer Activity
Edwyn Remadna, Anna Wilsmann, Nicolas Städler, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Tumor-associated stroma shapes the spatial tumor immune microenvironment of primary Ewing sarcomas
Christopher Kuo, Krinio Giannikou, N.-K. Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Identification of IFI27 involvement in the progression of neuroblastoma through bioinformatics analysis and experimental assays
Honghao Chen, Yan Mi, Xiaoping Cai, et al.
Journal of Molecular Histology (2025) Vol. 56, Iss. 2
Closed Access
Neuroblastoma risk decreased by NSUN3 rs7653521 C>T polymorphism in Chinese children
Meng Li, Xinxin Zhang, Chunlei Zhou, et al.
Chinese Medical Journal (2025)
Open Access
Principles of Immunotherapy and Novel Immunotherapeutic Agents for Pediatric Cancer Management
Zachary Morrison, Ali Suliman
(2025), pp. 1-12
Closed Access
Prospects for the Use of Antibody-Drug Conjugates in Cancer Therapy
A. O. Makarova, E. V. Svirshchevskaya, Mikhail Titov, et al.
Russian Journal of Bioorganic Chemistry (2025) Vol. 51, Iss. 2, pp. 556-573
Closed Access
Neuroblastoma: An Updated Review on Biology and Treatment
Suresh Mallepalli, Manoj Gupta, Ramakrishna Vadde
Current Drug Metabolism (2019) Vol. 20, Iss. 13, pp. 1014-1022
Closed Access | Times Cited: 33
Gangliosides and Neuroblastomas
Cara‐Lynne Schengrund
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5313-5313
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top